Pfizer says a new study suggests its drug Chantix can help smokers unwilling or unable to quit abruptly to reduce their smoking before actual quitting. But can a stop-smoking pill that is…
Frank Golhen, via Wikimedia CommonsThe stock gods decided to buy the dip on Tuesday, a day after the biggest sell-off in about three months. Despite a lack of market-moving economic reports, the…
Jon OggWe are now well past the end of 2013, and many strategists have mixed targets for the stock and bond markets in 2014. The last year brought gains of 26.5% in…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Friday, January 10.
With a new year comes new expectations. 24/7 Wall St. has generated a bullish and bearish scenario for 2014 in each stock of the Dow, including Pfizer and rival Merck & Co.
If one firm can create interest around a stock, it is Goldman Sachs. Investors have followed its Conviction Buy List for years, but 24/7 Wall St. has tracked many major changes to…
ThinkstockPfizer Inc.’s (NYSE: PFE) patent protecting popular erectile dysfunction drug Viagra from generic competition may not expire until April 2020, but Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has acquired rights to launch its…
thinkstockDecember 11, 2013: Markets opened lower again on Wednesday morning on another day of relatively light trading and yet more profit-taking. The DJIA closed down 0.81%, the S&P 500 closed down 1.13%,…
courtesy of VerizonThe short interest data for the end of November is out, and the results are somewhat surprising when it comes to the top high-yield safe dividends out there. Some of the…
GS.COMIt is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews vast numbers of research reports looking for the best stocks to buy…
ThinkstockThere is a trend at the end of each year followed by many income investors. This is the Dogs of the Dow, which is simply made up of the 10 Dow Jones…
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013. They include Apple, 3D Systems, Micron Technology and Tesla Motors.
ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies locally, but a new report from IMS Health shows that the total…
We have now seen the short interest reports from the October 31 settlement date and have compared them to the October 15 settlement date. This is important because it reflects the opinions…
Wikimedia CommonsPfizer Inc. (NYSE: PFE) reported third-quarter 2013 results before markets opened Tuesday morning. The drug maker posted adjusted diluted earnings per share (EPS) of $0.58 and revenues of $12.64 billion. In…
Paul Ausick 
